Qiyong Peter Liu

Title: **Innovator Spotlight: Qiyong Peter Liu**

Introduction

Qiyong Peter Liu is an accomplished inventor based in Newton, MA, who has significantly contributed to advancements in plasma products and protein stabilization technologies. With a remarkable portfolio of 16 patents, Liu's work is characterized by innovative solutions that enhance the stability and efficacy of blood plasma products.

Latest Patents

Liu's latest patent focuses on a novel blood plasma product, aimed at improving its storage and reconstitution properties. This spray-dried plasma composition exhibits several key characteristics: it is largely amorphous upon reconstitution, significantly reduces the presence of large particulates, maintains low residual moisture, and reconstitutes rapidly in less than four minutes. Additionally, this product demonstrates enhanced stability when stored under various temperatures and allows for longer storage durations. Importantly, it facilitates the recovery of delicate proteins, including von Willebrand's factor, while ensuring a normal plasma pH without requiring treatment or storage in carbon dioxide. Moreover, when reconstituted, the product shows reduced complement activation, indicating a further advancement in plasma technology.

Another significant patent issued to Liu presents formulations and methods for the contemporaneous stabilization of active proteins during spray drying and storage. This innovative method involves treating plasma with a physiologically compatible spray dry stable acidic substance prior to or during the spray drying process. As a result, it promotes greater recovery rates and long-term stabilization of dried plasma proteins, surpassing the outcomes observed in traditional methods.

Career Highlights

Qiyong Peter Liu has made notable contributions to the field through his roles at leading organizations such as Velico Medical, Inc. and The Brigham and Women's Hospital, Inc. His expertise has played a pivotal role in the development of groundbreaking solutions in medical technology, particularly in blood plasma treatment.

Collaborations

Throughout his career, Liu has collaborated with talented colleagues including Jihae Sohn and Henrik Clausen. These partnerships have fostered a productive environment for innovation, enabling the successful implementation of their collective knowledge and expertise in the pursuit of medical advancements.

Conclusion

In summary, Qiyong Peter Liu's innovative contributions to plasma product technology exemplify the power of invention in improving medical treatments. His 16 patents, particularly in the realms of blood plasma reconstitution and protein stabilization, showcase his dedication to enhancing patient care and advancing biotechnology. As Liu continues to explore new frontiers in his field, his work undoubtedly paves the way for future innovations in medical science.